Send me a link:

*Text messaging rates may apply.

 Dow Down 0.21% Nasdaq Up 0.34%

Epizyme, Inc. (EPZM)

-NasdaqGS
32.27 Up 1.86(6.12%) 12:26PM EDT - Nasdaq Real Time Price
Prev Close:30.41
Open:30.84
Bid:32.23 x 100
Ask:32.35 x 100
1y Target Est:42.50
Beta:3.513
Earnings Date:Jul 28 - Aug 1 (Est.)
Day's Range:30.51 - 32.50
52wk Range:18.10 - 42.71
Volume:125,142
Avg Vol (3m):238,989
Market Cap:1.06B
P/E (ttm):N/A
EPS (ttm):-0.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for EPZM

Comparison

Symbol% ChgMkt Cap
EPZMUp 6.12%1.06B
GSKDown 5.02%121.67B
NVSDown 0.25%216.03B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):13.70
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.81
Quarterly EPS Est (Jun-14) :-0.50
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Epizyme, Inc., a clinical stage biopharmaceutical company, discovers and develops personalized therapeutics for patients with genetically defined cancers. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback